NCT04385524View on ClinicalTrials.gov

Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 1, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

February 28, 2021

Conditions
Hepatitis B Virus
Interventions
BIOLOGICAL

Adjuvanted Hepatitis B Vaccine

Adjuvanted Hepatitis B vaccine will be provided to healthcare workers previously vaccinated with the standard 3-dose series of Hepatitis B vaccine but who have failed to respond to two complete 3-dose series

Sponsors
All Listed Sponsors
collaborator

Dynavax Technologies Corporation

INDUSTRY

lead

University of Louisville

OTHER